WebFind the latest Onconova Therapeutics, Inc. (ONTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. WebOnconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of -23.81% and 5%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo Finance
Web24 de mar. de 2024 · Company Description. Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological ... Web6 de abr. de 2024 · markets.businessinsider.com - March 23 at 1:22 PM. Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib. finance.yahoo.com - March 23 at 1:22 PM. Onconova Therapeutics, Inc. (NASDAQ:ONTX) Expected to Post Q1 2024 Earnings of ($0.27) Per … bixby addicts delphi
Onconova Therapeutics Stock Price Today (NASDAQ: ONTX) …
Web20 de mai. de 2024 · Onconova’s common stock will continue to trade on the Nasdaq Capital Market under the trading symbol “ONTX.” The new CUSIP number for the common stock following the reverse stock split is ... WebFind real-time ONTX - Onconova Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ONTX - Onconova Therapeutics Inc Stock quote - … WebFind the latest Onconova Therapeutics, Inc. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Onconova Therapeutics, Inc. (ONTX) NasdaqCM - NasdaqCM Real Time … bixby abandoned samsung